Prospective, observational, non-interventional, multicenter real-world evidence study on effectiveness and safety of treatment of patients with moderate to severe Chronic Hand Eczema with delgocitinib cream (20mg/g) (REACHED)

Study identification

• EU PAS number:
  EUPAS1000000731
• Study ID:
  1000000731
• Official title and acronym:
  Prospective, observational, non-interventional, multicenter real-world evidence study on effectiveness and safety of treatment of patients with moderate to severe Chronic Hand Eczema with delgocitinib cream (20mg/g) (REACHED)
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study status:
  Ongoing

Research institutions and networks

Institutions

Dermatologie Potsdam MVZ

Study timelines

Date when funding contract was signed

Actual:09/12/2024

Study start date

Actual:06/06/2025

Date of final study report

Planned:31/03/2028

Sources of funding

Pharmaceutical company and other private sector 

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

NIS-DELGO-2396